Linked Eye Disease

February 18, 2015 10:00 PM

13 0

WEDNESDAY, Feb. 18, 2015 (HealthDay News) -- A vision-robbing condition called diabetic macular edema can strike people with diabetes.

Now, a new study compared three leading drugs for the condition -- Avastin, Eylea and Lucentis -- and found that Eylea came out on top, at least for patients with "moderate" vision loss.

Read more

To category page